Prevalence of Diabetes and Hypertension in Colombia: A Systematic Review

Authors

DOI:

https://doi.org/10.17533/udea.rfnsp.v37n1a13

Keywords:

diabetes mellitus, hypertension, noncommunicable diseases

Abstract

Objective: To conduct a systematic review determining the prevalence of diabetes and hypertension among the adult population in Colombia. Methodology: A structured search was carried out in the electronic databases PubMed, SciELO and ProQuest, including studies published in Spanish and English from January 2000 to June 2016. Results: Four studies in hypertension and 2 in diabetes were selected. The overall prevalence of hypertension in the 4 selected studies ranged from 13.4% (95% CI:11.5-15.2) to 70.4% (95% CI no reported). The overall prevalence of diabetes in the 2 selected studies were 8.1(95% CI:6.8-9.5) and 8.9% (95% CI no reported). Conclusion: This review provides limited but useful evidence about the prevalence of two major noncommunicable diseases in Colombia. The results enhance the need of improving surveillance systems of risk factors of these diseases and standardizing methodological procedures for the estimation of prevalence studies.

|Abstract
= 1182 veces | PDF INGLÉS (ESPAÑOL (ESPAÑA))
= 321 veces|

Downloads

Download data is not yet available.

Author Biographies

Luis Fernando Gómez, Pontifical Xavierian University

Doctorate in medicine (MD), Master of Public Health (MPH). Pontifical Xavierian University, Colombia.

Mercedes Mora, Pontifical Xavierian University

MSc, Nutritionist. Pontifical Xavierian University, Colombia.

Stefania Riascos, Pontifical Xavierian University

Doctor. Pontifical Xavierian University, Colombia.

Diana Parra, Washington University

Doctorate (PhD), Master in Public Health (MPH), Physical Therapist. Washington University. United States of America.

References

(1). World Health Organization. Global status report on noncommunicable diseases 2014. Available at: http://apps.who.int/iris/bitstream/10665/148114/1/9789241564854_eng.pdf?ua=1 [Accessed 11th July 2016].

(2). Liu XM1, Liu YJ, Zhan J, He QQ. Overweight, obesity and risk of all-cause and cardiovascular mortality in patients with type 2 diabetes mellitus: a dose-response meta-analysis of prospective cohort studies. Eur J Epidemiol 2015;30(1):35-45.

(3). Lee C, Joseph L, Colosimo A, Dasqupta K. Mortality in diabetes compared with previous cardiovascular disease: a gender-specific meta-analysis. Diabetes Metab 2012;38(5):420-427.

(4). Stevens SL, Wood S, Koshiaris C, Law K, Glasziou P, Stevens RJ, McManus RJ. Blood pressure variability and cardiovascular disease: a systematic review and meta-analysis. BMJ 2016;354:j4098.

(5). Ettehad D, Emdin CA, Kiran A, Anderson SG, Callenger T, Emberson J, Chalmers J, Rodgers A, Rahimi K. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet 2016;387(10022):957-967.

(6). im SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2224–60.

(7). Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006,3(11):e442.

(8). World Health Organization. Global report on diabetes. Available at: http://apps.who.int/iris/bitstream/10665/204871/1/9789241565257_eng.pdf [Accessed 11th July 2016].

(9). World Health Organization. A global brief on hypertension: A silent killer, global public health crisis. Available at: http://ish-world.com/downloads/pdf/global_brief_hypertension.pdf [Accessed 15th July 2016].

(10). Global Burden of Disease Study, Institute for Health Metrics and Evaluation. Available in: http://vizhub.healthdata.org/gbd-compare/ [Accessed 1st July 2018].

(11). WHO| Guideline Sodium intake for adults and children Sodium intake for adults and children. [cited 2018 Jun 17]; Available from: http://apps.who.int/iris/bitstream/handle/10665/77985/9789241504836_eng.pdf;jsessionid=082F8CE6F9595F86C1F273CEDA437CEF?sequence=1

(12). Imamura F, Connor LO, Ye Z, Mursu J, Hayashino Y, Bhupathiraju SN, et al. Consumption of sugar sweetened beverages , artificially sweetened beverages , and fruit juice and incidence of type 2 diabetes : systematic review , meta-analysis , and estimation of population attributable fraction. 2015;1–12.

(13). Liu X, Zhang D, Liu Y, Sun X, Han C, Wang B, Ren Y, Zhou J, Zhao Y, Shi Y, Hu D, Zhang M. Dose-Response Association Between Physical Activity and Incident Hypertension: A Systematic Review and Meta-Analysis of Cohort Studies. Hypertension. 2017;69(5):813-820.

(14). Roerecke M, Tobe SW, Kaczorowski J, Bacon SL, Vafaei A, Hasan OSM, Krishnan RJ, Raifu AO, Rehm J. Sex-Specific Associations Between Alcohol Consumption and Incidence of Hypertension: A Systematic Review and Meta-Analysis of Cohort Studies. J Am Heart Assoc. 2018;7(13). Pii:e008202.

(15). Aune D, Norat T, Leitzmann M, Tonstad S, Vatten LJ. Physical activity and the risk of type 2 diabetes: a systematic review and dose-response meta-analysis. Eu J Epidemiol. 2015;30(7):529-542.

(16). Silva-Magliano E, Gaspar-Guedes L, Silva_freire E, Vergetti-Bloch K. Prevalence of arterial hypertension among Brazilian adolescents: systematic review and meta-analysis. BMC Public Health 2013;13:833.

(17). SURE Guides for preparing and using evidence-based policy briefs. Available in: http://www.sandy-campbell.com/sc/KTC_Module_1_files/KTP%20Module%201%20-%204.3c%20-%20SURE%20Guides%20-%2004%20deciding%20and%20describing%20options.pdf [Accessed 1st September 2016].

(18). Schargrodsky H, Hernandez-Hernandez R, Champagne BM, Silva H, Vinueza R, Silva Ayc ̧aguer LC et al. CARMELA Study Investigators. CARMELA: assessment of cardiovascular risk in seven Latin American cities. Am J Med 2008; 121: 58–65.

(19). Alayón A, Alvear C. Prevalencia de desórdenes del metabolismo de los glúcidos y perfil del diabético en Cartagena de Indias (Colombia). Salud Uninorte. 2005;22(1):20-8.

(20). Navarro-Lechuga E, Vargas-Moranth RF. Características epidemiológicas relacionadas con el género en hipertensos de raza negra. Salud Uninorte. 2009;25:88-100.

(21). Patiño-Villada FA, Arango-Vélez MA, Quintero-Velásquez MA. Factores de riesgo cardiovascular en una población urbana de Colombia. Rev Salud Pública. 2011;13(3):433-445.

(22). Gakidou E, Mallinger L, Abbott-Klafter J, Guerrero R, Villalpando S, Lopez-Ridaura R, Aekplakorn W, Naghavi M, Lim S, Lozano R, Murray JL. Management of diabetes and associated cardiovascular risk factors in seven countries: a comparison of data from national health examination surveys. Bull World Health Organ. 2011;89:172-183.

(23). Lucumí-Cuesta D. Disparities in hypertension in Colombia: A mixed method study. 2014. Available: https://deepblue.lib.umich.edu/bitstream/handle/2027.42/107278/dilucumi_1.pdf?sequence=1

(24). Cataño-Bedoya JU, Duque-Botero J, Naranjo-Gonzalez CA, Rua-Molina DC, Rosique-Gracia J et al. Prevalencia de factores de riesgo cardiovascular en indígenas embera-chami de Cristianía (Jardín), Antioquia. IAREIA 2014;28(1):5-16.

(25). Cano-Gutiérrez C, Reyes-Ortis CA, Samper-Ternent N, Gelvez-Rueda JS, Borda MJ. Prevalence and factors associated to hypertension among older adults in Bogotá, Colombia. Journal of Aging and Health. 2015,27(6):1046–1065.

(26). Fasce E, Campos I, Ibáñez P, Flores M, Zárate H, Román O, Fasce F. Trends in prevalence, awareness, treatment and control of hypertension in urban communities in Chile. J Hypertens. 2007,25(9):1807-11.

(27). Moreira JP, Moraes JR, Luiz RR. Prevalence of self-reported systemic hypertension in urban and rural environments in Brazil: a population-based study. Cad Saude Publica. 2013,29(1):62-72.

(28). Mendes T de A, Goldbaum M, Segri NJ, Barros MB, César CL, Carandina L. Factor associated with the prevalence of hypertension and control practices among elderly residents of São Paulo city, Brazil. Cad Saude Publica. 2013,29(11):2275-86.

(29). Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Himmelfarb CD, DePalma S, Gidding S, Jamerson KA, Jones DW, MacLaughlin EJ, Muntner P, Ovbiagele B, Smith Jr. SC, Spencer CC, Stafford RS, Taler SJ, Thomas RJ, Williams KA, Williamson JD, Wright JT. 2017 ACC/ AHA/ AAPA/ ABC/ACPM /AGS/APhA /ASH/ASPC/NMA /PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Journal of the American College of Cardiology. 2018, e 1 2 7 – 2 4 8.

(30). Cowie CC, Rust KF, Byrd-Holt DD, Eberhardt MS, Flegal KM, Engelgau MM, Saydah SH, Williams DE, Geiss LS, Gregg EW. Prevalence of diabetes and impaired fasting glucose in adults in the U.S. populations: National Health and Nutrition Examination Survey 1999-2002. Diabetes Care. 2006,29(6):1263-8.31. Olives C, Myerson R, Mokdad AH, Murray CJ, Lim SS. Prevalence, awareness, treatment, and control of hypertension in United States counties, 2001-2009. PLoS One. 2013,8(4):e60308.

(31). Olives C, Myerson R, Mokdad AH, Murray CJ, Lim SS. Prevalence, awareness, treatment, and control of hypertension in United States counties, 2001-2009. PLoS One. 2013,8(4):e60308.

Published

2019-01-30

How to Cite

1.
Gómez LF, Mora M, Riascos S, Parra D. Prevalence of Diabetes and Hypertension in Colombia: A Systematic Review. Rev. Fac. Nac. Salud Pública [Internet]. 2019 Jan. 30 [cited 2025 Feb. 22];37(1):87-95. Available from: https://revistas.udea.edu.co/index.php/fnsp/article/view/327780

Issue

Section

Condiciones de salud

Most read articles by the same author(s)